← Back to all signals
RESEARCH PAPER ANALYSIS

Exploring the Discrepancy Between Subjective and Objective Measures of Executive Functions in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia.

AI interpretation is pending for this paper.

Open original publication →
PMID39552427
JournalJournal of adolescent and young adult oncology
Publication Date2024-11-18
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

Purpose: Childhood acute lymphoblastic leukemia (ALL) is associated with executive dysfunction in long-term survivorship. This is evidenced by subjective and objective measures of executive functions (EFs). However, the two measures do not always align, and the EF discrepancy in this population is understudied. This cross-sectional study aimed to examine the association between global measures of subjective and objective EF in young adult (YA) survivors of childhood ALL. Second, we aimed to explore how psychological distress, fatigue, self-efficacy, and estimated IQ relate to the discrepancy between these measures. Methods: A total of 53 subjects (age 18-34) participated in a clinical trial baseline assessment (clinicaltrials.gov NCT04541056). The Behavior Rating Inventory of Executive Function for Adults assessed subjective EFs. Results from six neurocognitive tests were combined to represent objective EFs. Discrepancy scores were calculated by subtracting the objective EF composite score from the subjective EF score. Spearman's correlations and simple and multiple linear regression analyses were performed to explore associations and predictors for the global EF discrepancy. Results: Subjective and objective measures of EF were moderately correlated (rs = 0.407). The regression analyses showed that psychological distress (R2 = 0.44), fatigue (R2 = 0.29), and self-efficacy (R2 = 0.24) significantly predicted the global EF discrepancy (p < .001). Only psychological distress explained unique variation (B = -0.46). Conclusion: Neurocognitive tests and self-reports offer valuable insights into EF assessment for YA survivors. Psychological distress emerged as the most central contributor to the overall EF discrepancy. Consequently, screening for anxiety and depression alongside subjective EF complaints will be of significance.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Effects of early menarche on adolescent health: a single-centre retrospective study. Pediatric endocrinology, diabetes, and metabolism 68.4 2 Changes in the diagnosis and management of polycystic ovary syndrome in adolescents based on recommendations of scientific societies over the last decade. Pediatric endocrinology, diabetes, and metabolism 74.8 3 Development of a Behavioral Intervention, Increasing HPV Vaccine Uptake-Delivered in Dental Settings (HPV Vaccine Uptake-DDS). Behavioral medicine (Washington, D.C.) 61.4 4 A non-inferiority randomized controlled trial comparing nebulized fentanyl and intravenous morphine for acute pain management in the emergency department. BMC emergency medicine 77.6 5 Prevalence and behavioral factors associated with penile and rectal HPV infection among men who have sex with men in Kenya. BMC infectious diseases 71.0 6 Knowledge of cervical cancer and uptake of HPV vaccine among in-school adolescent girls in Kwara State, Nigeria. Infectious agents and cancer 75.7 7 Association of coping pathways with anxiety symptoms in children with hematological cancers: a cross-sectional study using regression and fuzzy-set qualitative comparative analysis. BMC psychology 70.4 8 Clinician vs. self-assessment of mFG hirsutism scores in PCOS: can patient self-assessment serve as a reliable screening and triage tool? BMC women's health 61.5 9 Impact of Obesity on Chemotherapy Pharmacokinetics, Toxicity, and Survival Outcomes in Pediatric Acute Lymphoblastic Leukemia. Cureus 75.0 10 Head & Neck and Shoulder Desmoid-Type Fibromatosis: Presentation and Natural History of These Ultra-Rare Locations. Cancer medicine 70.7 11 Leveraging Digital Histopathology to Build Capacity and Collaboration Toward the Diagnosis of Pediatric Solid Tumors in Mexico. JCO global oncology 59.9 12 [Newborn with neurofibromatosis type 1 and meningoencephalocele]. Ugeskrift for laeger 47.5 13 Central nervous system, cranial, and cerebrovascular conditions beyond the Kimonis criteria in patients with Gorlin syndrome: a retrospective cohort study. Frontiers in neurology 67.0 14 Resistance mechanisms and translational bottlenecks in CAR-T cell therapy for pediatric acute lymphoblastic leukemia: a perspective. Frontiers in immunology 84.27 15 Gut microbiota dysbiosis in pediatric acute lymphoblastic leukemia: clinical consequences, mechanistic insights, and microbiota-targeted interventions. Frontiers in pediatrics 82.6 16 Ewing sarcoma and paediatric cancer burden: we need more robust registries. Lancet regional health. Americas 47.5 17 Health and economic benefits of air quality improvements in France through diverse net-zero transition scenarios by 2050. Environment international 57.5 18 [Assessment of myocardial injury following anthracycline chemotherapy in children with leukemia by echocardiography]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 69.64 19 Thyroid Differentiation Score as a Molecular Bridge Between Genotype, Tumor Biology, and Radioiodine Theranostics in Thyroid Cancer. Endocrine-related cancer 64.7 20 [Development and validation of a prediction model for postoperative recurrence risk of ovarian endometriotic cysts based on preoperative imaging and clinical biomarkers]. Zhonghua yi xue za zhi 71.75 21 Lactation Management in Patients With Cancer: An Evidence-Based Framework for Surgical Practice. The American surgeon 71.0 22 Evidence-Based Recommendations for School Integration Programs Following Cancer: A Systematic Review. Journal of pediatric hematology/oncology nursing 70.0 23 Discharge Planning in Children With Cancer: Components, Strategies, and Outcomes-A Scoping Review (2021-2025). Journal of pediatric hematology/oncology nursing 58.0 24 Intervention to Support Families of Survivors of Pediatric Brain Tumor: A Scoping Review. Journal of pediatric hematology/oncology nursing 72.7 25 The role of allogeneic hematopoietic stem cell transplantation in adults with mature T-cell lymphomas. The Cochrane database of systematic reviews 88.6 26 Relative frequency of non-Wilms renal tumours in children: an institutional experience from a national tertiary referral centre in Malaysia. Pediatric surgery international 63.4 27 Childhood Cancer Risk After Assisted Reproductive Technology. JAMA 50.0 28 Long-Term Outcomes and Biomarker Correlates of a Multi-Institutional Phase II Study of Hypofractionated Proton Beam Therapy for Unresectable Primary Liver Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 83.39 29 The Burden of Early-Onset Gastric Cancer From 1990 to 2021: A Systematic Analysis for the Global Burden of Disease Study 2021. Journal of clinical gastroenterology 58.0 30 Decomposing the decline in life expectancy at birth by cause of death during the COVID-19 pandemic in Canada. Health reports 38.5 31 Integrating Surgery and Immunotherapy in the Treatment of Childhood Orbital Melanoma: A Case Report and the Literature Review. Ophthalmic plastic and reconstructive surgery 62.56 32 Co-occurrence of retinoblastoma and oculocutaneous albinism in a Mexican patient: a case report. Ophthalmic genetics 51.9
PATIENT-FRIENDLY SUMMARY

Exploring the Discrepancy Between Subjective and Objective Measures of Executive Functions in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic